Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cartesian Therapeutics (RNAC) Interest Coverage Ratio (2016 - 2023)

Cartesian Therapeutics (RNAC) has disclosed Interest Coverage Ratio for 9 consecutive years, with 10.26 as the latest value for Q3 2023.

  • For Q3 2023, Interest Coverage Ratio fell 414.76% year-over-year to 10.26; the TTM value through Jun 2024 reached 38.48, down 158.84%, while the annual FY2023 figure was 30.5, 735.96% down from the prior year.
  • Interest Coverage Ratio hit 10.26 in Q3 2023 for Cartesian Therapeutics, up from 24.78 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 19.38 in Q2 2022 and bottomed at 79.84 in Q2 2020.
  • Average Interest Coverage Ratio over 5 years is 19.9, with a median of 11.08 recorded in 2020.
  • Year-over-year, Interest Coverage Ratio soared 2949.22% in 2022 and then crashed 414.76% in 2023.
  • Cartesian Therapeutics' Interest Coverage Ratio stood at 37.52 in 2019, then skyrocketed by 70.48% to 11.08 in 2020, then soared by 151.78% to 5.74 in 2021, then plummeted by 283.55% to 10.53 in 2022, then increased by 2.51% to 10.26 in 2023.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 10.26, 24.78, and 22.75 for Q3 2023, Q2 2023, and Q1 2023 respectively.